Income StatementBalance SheetCash FlowSegments
Cardinal Health logo

Cardinal Health Cash Flow Statement

Operating, investing, and financing cash movements

Cardinal Health generated $5.0B in operating cash flow over the trailing twelve months. After $617.0M in capital expenditures, free cash flow was $4.4B. Free cash flow increased 0.8% year-over-year. Based on the Q1 2026 filing.

Net Cash From Operating (TTM)$5.0BNet Cash From Investing (TTM)-$3.9BNet Cash From Financing (TTM)-$456.0MCapital Expenditures (TTM)$617.0MDepreciation And Amortization Cf (TTM)$924.0MNet Change In Cash (TTM)-$425.0M
Latest FilingQ1 2026
Report Date2026-04-30
Market Cap$43.6B
P/E Ratio28.07
ROE-53.81%

Investing

MetricQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Acquisitions, net of cash acquired$1.1B$2.8B$1.4B$41.0M$1.9B$42.0M
Capital expenditures$99.0M$126.0M$232.0M$108.0M$131.0M$146.0M
Proceeds from short-term investment in time deposit$50.0M$50.0M$50.0M———
Proceeds from disposals of property, plant and equipment$0.0$3.0M————
Net cash from investing activities-$976.0M-$2.9B-$1.6B-$142.0M-$2.0B-$181.0M

Operating

MetricQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Change in accounts payable$924.0M$1.4B$1.8B$2.1B$2.0B-$1.2B
Change in inventories$1.3B-$758.0M$607.0M$736.0M$2.5B-$2.1B
Other working capital changes$133.0M-$107.0M$72.0M$699.0M-$89.0M$63.0M
Change in receivables$541.0M$114.0M$466.0M$539.0M-$341.0M$17.0M
Deferred income taxes$60.8M$60.8M$60.8M———
Depreciation and amortization$192.0M$207.0M$209.0M$233.0M$234.0M$248.0M
Net cash from operating activities-$400.0M$2.9B$1.5B$973.0M$686.0M$1.8B
Net income$401.0M$508.0M$243.0M$454.0M$471.0M$380.0M
Impairments and loss on sale of other investments-$750.0K-$750.0K-$750.0K———
Gain (Loss) on Sale of Assets and Asset Impairment Charges-$3.0M$17.0M-$33.0M-$2.0M$14.0M-$185.0M
Accounts Receivable, Credit Loss Expense (Reversal)$12.0M$13.0M$12.0M$13.0M$14.0M$20.0M
Stock-based compensation$30.0M$31.0M$153.0M$93.0M$87.0M$129.0M

Financing

MetricQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Repayments of debt$414.0M$11.0M$11.0M$512.0M$12.0M$113.0M
Dividends paid$122.0M$124.0M$120.0M$129.0M$122.0M$120.0M
Net tax withholding from share-based compensation$13.0M$3.0M-$1.0M-$80.0M-$1.0M$2.0M
Payments to Noncontrolling Interests$4.0M$3.0M$5.0M$3.0M$1.0M$4.0M
Net cash from financing activities$2.3B-$507.0M$656.0M-$110.0M-$519.0M-$483.0M
Repurchases of common stock$15.0M$375.0M$0.0$375.0M$383.0M$250.0M

Free Cash Flow

MetricQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Free cash flow-$499.0M$2.8B$1.3B$865.0M$555.0M$1.7B

Other

MetricQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Effect of exchange rate changes on cash-$12.0M$4.0M-$4.0M-$2.0M-$3.0M$1.0M
Net increase (decrease) in cash$943.0M-$484.0M—$719.0M-$1.8B$1.2B
Increase (decrease) in other investing items, net-$1.0M-$3.0M$4.0M$7.0M$4.0M-$20.0M

Supplemental

MetricQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Interest paid$78.8M$78.8M$78.8M———
Income Taxes Paid, Net$111.0M$111.0M$111.0M———